Chemoinformaics analysis of 4,6-Dimethyl-5-hepten-2-one
| Molecular Weight | 140.226 | nRot | 3 |
| Heavy Atom Molecular Weight | 124.098 | nRig | 2 |
| Exact Molecular Weight | 140.12 | nRing | 0 |
| Solubility: LogS | -2.349 | nHRing | 0 |
| Solubility: LogP | 2.487 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 26.5007 |
| nHD | 0 | BPOL | 16.9193 |
| QED | 0.551 |
| Synth | 3.304 |
| Natural Product Likeliness | 1.837 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.54 |
| Pgp-sub | 0.014 |
| HIA | 0.014 |
| CACO-2 | -4.459 |
| MDCK | 0.0000205 |
| BBB | 0.993 |
| PPB | 0.830173 |
| VDSS | 1.824 |
| FU | 0.185061 |
| CYP1A2-inh | 0.464 |
| CYP1A2-sub | 0.783 |
| CYP2c19-inh | 0.167 |
| CYP2c19-sub | 0.918 |
| CYP2c9-inh | 0.037 |
| CYP2c9-sub | 0.716 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.588 |
| CYP3a4-inh | 0.019 |
| CYP3a4-sub | 0.328 |
| CL | 11.487 |
| T12 | 0.682 |
| hERG | 0.007 |
| Ames | 0.013 |
| ROA | 0.019 |
| SkinSen | 0.21 |
| Carcinogencity | 0.162 |
| EI | 0.985 |
| Respiratory | 0.017 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.947614 |